NCT03815058
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03815058
Title A Study to Evaluate The Efficacy And Safety Of RO7198457 In Combination With Pembrolizumab Versus Pembrolizumab Alone In Participants With Previously Untreated Advanced Melanoma.
Acronym IMCODE001
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | ESP | DEU | BEL | AUS

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center Duarte California 91010 United States Details
University of California San Diego Moores Cancer Center La Jolla California 92037 United States Details
UCSF Comprehensive Cancer Ctr San Francisco California 94115 United States Details
University of Colorado Denver Colorado 80262 United States Details
Cancer Specialists Jacksonville Florida 32256 United States Details
Moffitt McKinley Outpatient Center Tampa Florida 33612 United States Details
Atlanta Cancer Care Alpharetta Georgia 30005 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Massachusetts General Hospital. Boston Massachusetts 02114 United States Details
Washington University St Louis Missouri 63110 United States Details
Case Western Research University Cleveland Ohio 44106-5067 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Sarah Cannon Research Institute / Tennessee Oncology Nashville Tennessee 37203 United States Details
Intermountain Surgical Oncology Murray Utah 84107 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
University of Virginia Charlottesville Virginia 22906 United States Details
Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
Liverpool Hospital Liverpool New South Wales 2170 Australia Details
The Queen Elizabeth Hospital Woodville South South Australia 5011 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
Alfred Hospital Melbourne Victoria 3181 Australia Details
St. John of God - Subiaco Hospital Subiaco Western Australia 6008 Australia Details
Antwerp University Hospital Edegem 2650 Belgium Details
Sint Augustinus Wilrijk Wilrijk 2610 Belgium Details
Elbe Kliniken Stade-Buxtehude GmbH Buxtehude 21614 Germany Details
Universitätsklinikum Koeln Cologne 50937 Germany Details
Universitatsklinikum Eppendorf Hamburg 20246 Germany Details
Universitätsklinikum Heidelberg Heidelberg 69120 Germany Details
Uni Schleswig-Holstein Lübeck 23562 Germany Details
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR, Hautklinik und Poliklinik Mainz 55131 Germany Details
Med. Fakultat Mannheim der Universitat Heidelberg Mannheim 68167 Germany Details
Fachklinik Hornheide Münster 48157 Germany Details
Universitätshautk. Tübingen Tübingen 72076 Germany Details
Clinica Universidad de Navarra Pamplona Navarre 31008 Spain Details
Instituto Oncológico Dr. Rosell Barcelona 08028 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Hospital Clinic de Barcelona Barcelona 08036 Spain Details
Hospital General Universitario Gregorio Marañon Madrid 28007 Spain Details
Hospital Universitario La Paz Madrid 280146 Spain Details
Hospital Universitario Virgen Macarena Seville 41009 Spain Details
Barts and The London London EC1M 6BQ United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field